These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29675590)

  • 1. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study.
    Thicoïpé A; Laharie D; Smith D; Chabrun E; Rullier A; Poullenot F; Rullier E; Denost Q
    Int J Colorectal Dis; 2018 Jul; 33(7):963-966. PubMed ID: 29675590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome.
    Hrabe JE; Byrn JC; Button AM; Zamba GK; Kapadia MR; Mezhir JJ
    J Surg Oncol; 2014 Feb; 109(2):117-21. PubMed ID: 24132737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival.
    Vitali F; Wein A; Rath T; Eckstein M; Neufert C; Siebler J; Atreya R; Hartmann A; Hohenberger W; Weber K; Neurath MF; Grützmann R; Merkel S
    Int J Colorectal Dis; 2022 Feb; 37(2):381-391. PubMed ID: 34865179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.
    Axelrad J; Kriplani A; Ozbek U; Harpaz N; Colombel JF; Itzkowitz S; Holcombe RF; Ang C
    Clin Colorectal Cancer; 2017 Sep; 16(3):e205-e210. PubMed ID: 27742264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer prognosis among patients with inflammatory bowel disease.
    Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
    Leowardi C; Schneider ML; Hinz U; Harnoss JM; Tarantino I; Lasitschka F; Ulrich A; Büchler MW; Kadmon M
    Ann Surg Oncol; 2016 Mar; 23(3):870-6. PubMed ID: 26467453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
    Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
    Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.
    Reynolds IS; O'Toole A; Deasy J; McNamara DA; Burke JP
    Int J Colorectal Dis; 2017 Apr; 32(4):443-451. PubMed ID: 28078433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colitis-Associated Colorectal Cancer Survival is Comparable to Sporadic Cases after Surgery: a Matched-Pair Analysis.
    Raje P; Sonal S; Qwaider YZ; Sell NM; Stafford CE; Boudreau C; Schneider D; Ike A; Kunitake H; Berger DL; Ricciardi R; Bordeianou LG; Cauley CE; Lee GC; Goldstone RN
    J Gastrointest Surg; 2023 Jul; 27(7):1423-1428. PubMed ID: 37165158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.
    Renz BW; Thasler WE; Preissler G; Heide T; Khalil PN; Mikhailov M; Jauch KW; Kreis ME; Rentsch M; Kleespies A
    J Gastrointest Surg; 2013 May; 17(5):981-90. PubMed ID: 23475629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.
    Ali RA; Dooley C; Comber H; Newell J; Egan LJ
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits.
    Chang BW; Kumar AM; Koyfman SA; Kalady M; Lavery I; Abdel-Wahab M
    Int J Colorectal Dis; 2015 Mar; 30(3):403-8. PubMed ID: 25564345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
    Herszényi L; Barabás L; Miheller P; Tulassay Z
    Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
    Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
    Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
    Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
    Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Bogach J; Pond G; Eskicioglu C; Seow H
    Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
    Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
    World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
    Du L; Kim JJ; Shen J; Chen B; Dai N
    Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.